Your browser is no longer supported. Please, upgrade your browser.
Settings
BSTC BioSpecifics Technologies Corp. daily Stock Chart
BSTC [NASD]
BioSpecifics Technologies Corp.
Index- P/E27.09 EPS (ttm)2.40 Insider Own26.76% Shs Outstand7.06M Perf Week-6.14%
Market Cap458.97M Forward P/E23.38 EPS next Y2.78 Insider Trans0.00% Shs Float5.33M Perf Month-6.73%
Income17.60M PEG1.23 EPS next Q0.68 Inst Own61.30% Short Float3.91% Perf Quarter3.52%
Sales29.80M P/S15.40 EPS this Y8.70% Inst Trans3.54% Short Ratio4.73 Perf Half Y11.76%
Book/sh12.60 P/B5.16 EPS next Y11.20% ROA20.70% Target Price81.00 Perf Year49.79%
Cash/sh10.17 P/C6.39 EPS next 5Y22.00% ROE21.80% 52W Range40.54 - 73.31 Perf YTD7.28%
Dividend- P/FCF40.26 EPS past 5Y31.80% ROI17.40% 52W High-11.32% Beta1.30
Dividend %- Quick Ratio48.40 Sales past 5Y19.70% Gross Margin- 52W Low60.36% ATR2.69
Employees5 Current Ratio48.40 Sales Q/Q26.20% Oper. Margin70.50% RSI (14)41.95 Volatility4.33% 3.99%
OptionableNo Debt/Eq0.00 EPS Q/Q84.70% Profit Margin59.90% Rel Volume0.97 Prev Close67.78
ShortableYes LT Debt/Eq0.00 EarningsMar 20 Payout0.00% Avg Volume44.12K Price65.01
Recom- SMA20-5.19% SMA50-2.84% SMA20013.58% Volume42,647 Change-4.09%
Nov-13-17Reiterated H.C. Wainwright Buy $72 → $65
Mar-08-16Initiated Rodman & Renshaw Buy $60
Jul-16-15Initiated MLV & Co Buy $76
Nov-11-14Reiterated MKM Partners Buy $38 → $46
Aug-12-14Reiterated MKM Partners Buy $28 → $38
Jan-09-14Reiterated MKM Partners Buy $24.50 → $28
Dec-09-13Reiterated MKM Partners Buy $23.50 → $24.50
Apr-05-12Initiated MKM Partners Buy $26.50
Mar-15-12Initiated Stifel Nicolaus Buy $29
Jun-15-09Initiated Hapoalim Outperform $40
Mar-22-19 08:01AM  4 Top Stocks to Buy for Superb Earnings Growth Zacks
Mar-20-19 09:00AM  BioSpecifics (BSTC) Upgraded to Strong Buy: Here's What You Should Know Zacks
Mar-18-19 08:01AM  BioSpecifics Technologies Corp. Announces Passing of President Thomas L. Wegman PR Newswire
Mar-05-19 04:36PM  What's in Store for BioSpecifics (BSTC) This Earnings Season? Zacks
Feb-21-19 11:27AM  Is BioSpecifics Technologies Corp. (NASDAQ:BSTC) A Volatile Stock? Simply Wall St.
Feb-04-19 07:35AM  Analysis: Positioning to Benefit within Amarin, Retrophin, Sunrun, BioSpecifics Technologies, Arbutus Biopharma, and TOCAGEN INC Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +5.83%
Jan-28-19 09:32AM  BioSpecifics (BSTC) Upgraded to Buy: Here's What You Should Know Zacks
Jan-17-19 09:30AM  Is BioSpecifics Technologies (BSTC) Stock Outpacing Its Medical Peers This Year? Zacks
Jan-16-19 10:36AM  Is BioSpecifics Technologies Corp.s (NASDAQ:BSTC) Balance Sheet Strong Enough To Weather A Storm? Simply Wall St.
Jan-11-19 10:32AM  Ocular (OCUL) Submits an sNDA for Eye Pain Drug Dextenza Zacks
Jan-10-19 11:00AM  INSYS Therapeutics Rises on Dose-Ranging Allergy Study Data Zacks
08:43AM  Weakness Seen in Champions Oncology (CSBR) Estimates: Should You Stay Away? Zacks
Jan-09-19 09:45AM  Karyopharm Files MAA for Myeloma Candidate Selinexor in EU Zacks
Jan-07-19 12:42PM  Neurocrine Gives Ingrezza Sales View, Updates on Pipeline Zacks
Jan-03-19 10:29AM  Spectrum Pharma Fully Enrolls 1St Cohort in Poziotinib Study Zacks
10:26AM  Flexion Starts Phase III Enrollment on Zilretta for Hip OA Zacks
Jan-02-19 09:25AM  Portola Up as Large-Scale Andexxa Production Gets FDA Nod Zacks
Dec-28-18 09:45AM  Spectrum Pharma Files BLA for Neutropenia Candidate Rolontis Zacks
Dec-25-18 09:30AM  Is BioSpecifics Technologies (BSTC) Outperforming Other Medical Stocks This Year? Zacks
Dec-19-18 03:09PM  Small Drug Stocks Near-Term Outlook Positive, Despite Headwinds Zacks
Dec-17-18 10:29AM  Heres What BioSpecifics Technologies Corp.s (NASDAQ:BSTC) P/E Is Telling Us Simply Wall St.
Dec-12-18 10:15AM  Portola (PTLA) Down as CHMP Defers Review Date for Ondexxya Zacks
Dec-11-18 05:44PM  Jazz (JAZZ) Increases Share Buyback Authorization by $400M Zacks
09:22AM  Novan Announces Top-Line Data From Mid-Stage Molluscum Study Zacks
08:40AM  Why Tilray (TLRY) Could Be Positioned for a Slump Zacks
Dec-06-18 08:46AM  Should You Get Rid of Aerie Pharmaceuticals (AERI) Now? Zacks
Nov-29-18 04:47PM  Theravance Pipeline Strong, Plans Yupelri Launch by Year End Zacks
Nov-28-18 10:20AM  Theravance's Respiratory Disease JAK Inhibitor Enters Phase I Zacks
08:15AM  Market Trends Toward New Normal in Amarin, BioSpecifics Technologies, Cavco Industries, Iconix Brand Group, A-Mark Precious Metals, and Core-Mark Holding Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-27-18 01:26PM  Is BioSpecifics Technologies Corp. (NASDAQ:BSTC) Worthy of Your Portfolio? Insider Monkey
Nov-21-18 11:15AM  Theravance JAK Inhibitor Enters Phase II for Crohn's Disease Zacks
09:58AM  IntelGenx's NDA Resubmission for Rizaport Gets FDA Acceptance Zacks
Nov-20-18 04:25PM  IBD Stock Of The Day Breezes Toward Breakout On New Inhaler Uses Investor's Business Daily
08:45AM  Galmed Pharmaceuticals (GLMD) in Focus: Stock Moves 6.2% Higher Zacks
08:33AM  TESARO (TSRO) Jumps: Stock Rises 5.4% Zacks
Nov-15-18 04:30PM  BioSpecifics Technologies Corp. Appoints Ron Law, Ph.D, J.D., as Senior Vice President of Business Development PR Newswire
02:15PM  Managers Of This Fund Like The Outlook For Small-Cap Stocks Investor's Business Daily
12:35PM  Is BioSpecifics Technologies Corp (NASDAQ:BSTC) Excessively Paying Its CEO? Simply Wall St.
Nov-09-18 09:20AM  BioSpecifics Technologies (BSTC) Q3 Earnings and Revenues Beat Estimates Zacks
08:13AM  BioSpecifics: 3Q Earnings Snapshot Associated Press
08:01AM  BioSpecifics Technologies Corp. Reports Third Quarter 2018 Financial Results PR Newswire
Nov-06-18 10:31AM  What's in the Cards for BioSpecifics (BSTC) in Q3 Earnings? Zacks
Nov-02-18 10:30AM  BioSpecifics Technologies (BSTC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Oct-31-18 04:30PM  BioSpecifics Technologies Corp. Announces Positive Topline Results from Phase 1 Study of CCH for the Treatment of Uterine Fibroids PR Newswire
Oct-25-18 04:36PM  IBD Stock Of The Day Outperforms Biotech Sector In A Rough October Investor's Business Daily
Oct-19-18 08:45AM  Investor Expectations to Drive Momentum within Ultrapar Participacoes S.A, BioSpecifics Technologies, GSV Capital, 58, Mitel Networks, and Amarin Discovering Underlying Factors of Influence GlobeNewswire
Oct-09-18 10:01AM  Affimed Down After Clinical Hold on Two Early-Stage Studies Zacks
Oct-08-18 09:44AM  Zacks.com highlights: OptimizeRX, Verso, BioSpecifics Technologies and Luxfer Holdings Zacks
Oct-05-18 08:56AM  BioLineRx (BLRX) in Focus: Stock Moves 7.5% Higher Zacks
08:40AM  Champions Oncology (CSBR) Soars: Stock Adds 10.7% in Session Zacks
07:48AM  4 Stocks With Recent Price Strength to Maximize Your Gains Zacks
Oct-03-18 08:40AM  Infinity Pharmaceuticals (INFI) Looks Good: Stock Adds 6.5% in Session Zacks
Oct-02-18 09:40AM  Is BioSpecifics Technologies (BSTC) Stock Outpacing Its Medical Peers This Year? Zacks
Oct-01-18 11:38AM  Endo Recalls 2 Lots of Robaxin Tablets Due to Labeling Error Zacks
Sep-28-18 10:06AM  Aldeyra Therapeutics (ALDX) Looks Good: Stock Adds 7.5% in Session Zacks
Sep-27-18 09:12AM  Aldeyra Surges on Positive Dry Eye Study Data on Reproxalap Zacks
08:35AM  Adamis Pharmaceuticals (ADMP) in Focus: Stock Moves 8% Higher Zacks
Sep-26-18 11:14AM  Portola's (PTLA) Lymphoma Candidate Gets Orphan Drug Status Zacks
Sep-24-18 02:13PM  Why BioSpecifics Technologies Corps (NASDAQ:BSTC) ROE Of 15.7% Does Not Tell The Whole Story Simply Wall St.
Sep-20-18 11:40AM  Molecular Templates Surges 50%, Inks Cancer Deal With Takeda Zacks
07:37AM  Zacks.com highlights: Champions Oncology, STAAR Surgical, Boingo Wireless, Verso and BioSpecifics Technologies Zacks
Sep-19-18 07:48AM  5 Stocks With Recent Price Strength to Strengthen Portfolio Zacks
Sep-18-18 11:18AM  United Therapeutics In-Licenses Rights to IPF Candidate Zacks
Sep-11-18 08:51AM  Tilray (TLRY) Looks Good: Stock Adds 8.5% in Session Zacks
07:11AM  The Zacks Analyst Blog Highlights: AeroVironment, BioSpecifics, Codexis, Avid and American Outdoor Zacks
Sep-10-18 09:23AM  5 Top-Ranked Nasdaq Stocks Defying the Worst September Start Zacks
Sep-07-18 08:57AM  Spectrum Pharmaceuticals (SPPI) Catches Eye: Stock Jumps 5.7% Zacks +6.33%
Sep-06-18 08:57AM  Tesaro (TSRO) Surges: Stock Moves 5.5% Higher Zacks
08:38AM  What Makes Taro Pharmaceutical (TARO) a Strong Sell? Zacks
Sep-05-18 04:44PM  Biogen Begins Phase III Study on Ischemic Stroke Candidate Zacks
09:24AM  Zacks.com highlights: Verso, Johnson Outdoors, BioSpecifics Technologies and Luxfer Holdings Zacks
Sep-04-18 07:27AM  4 Stocks With Recent Price Strength to Maximize Your Gains Zacks
Aug-30-18 08:33AM  Affimed (AFMD) Soars: Stock Adds 10.8% in Session Zacks
08:01AM  BioSpecifics Technologies Corp. to Present at Two Upcoming September Conferences PR Newswire
Aug-28-18 10:27AM  Esperion (ESPR) Combination Regimen Lowers Bad Cholesterol Zacks
Aug-27-18 09:56AM  Portola Pharmaceuticals (PTLA) Jumps: Stock Rises 9.1% Zacks
09:27AM  Jazz's (JAZZ) Leukemia Drug Vyxeos Gets Approval in Europe Zacks
Aug-22-18 09:54AM  Ironwood's Linzess Gets Approval in Japan for New Indication Zacks
09:07AM  VIVUS' (VVUS) Qsymia Falters in a Highly Competitive Market Zacks
Aug-21-18 04:01PM  IBD Stock Of The Day: Vertex Pharma Nears Third Breakout Of 2018 Investor's Business Daily
10:09AM  Lannett Set to Lose Distribution Agreement With Key Supplier Zacks
08:20AM  Market Trends Toward New Normal in Addus HomeCare, Sandstorm Gold, BioSpecifics Technologies, Itau Unibanco Holding S.A, Akers Biosciences, and Kosmos Energy Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Aug-20-18 08:48AM  Zacks.com highlights: PCM, STAAR Surgical, Verso, Johnson Outdoors and BioSpecifics Technologies Zacks
Aug-17-18 06:49AM  5 Stocks With Recent Price Strength to Enhance Your Returns Zacks
Aug-09-18 10:45AM  BioSpecifics Technologies (BSTC) Q2 Earnings Top Estimates Zacks
09:41AM  BioSpecifics: 2Q Earnings Snapshot Associated Press
08:01AM  BioSpecifics Technologies Corp. Reports Second Quarter 2018 Financial Results PR Newswire
Jun-06-18 07:35AM  Investor Expectations to Drive Momentum within Capital Product Partners, Nova Measuring Instruments, BioSpecifics Technologies, Itau Unibanco Holding S.A., CNB Financial, and Laureate Education Discovering Underlying Factors of Influence GlobeNewswire
May-09-18 08:52AM  Valeant Pharmaceuticals (VRX) Catches Eye: Stock Jumps 8.9% Zacks
08:36AM  BioSpecifics: 1Q Earnings Snapshot Associated Press
08:01AM  BioSpecifics Technologies Corp. Reports First Quarter 2018 Financial Results PR Newswire
Apr-12-18 06:55PM  Should BioSpecifics Technologies Corps (NASDAQ:BSTC) Recent Earnings Worry You? Simply Wall St.
Apr-11-18 08:20AM  New Research: Key Drivers of Growth for Talend S.A, Chipmos Technologies, POSCO, Horizon Pharma Public, BioSpecifics Technologies, and Arbutus Biopharma Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Apr-10-18 08:43AM  What Falling Estimates & Price Mean for Adamis Pharmaceuticals (ADMP) Zacks
Apr-09-18 08:37AM  Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 12.9% in Session Zacks
Apr-06-18 08:43AM  Falling Earnings Estimates Signal Weakness Ahead for Karyopharm Therapeutics (KPTI) Zacks
08:38AM  Why Flexion Therapeutics (FLXN) Could Be Positioned for a Slump Zacks
Mar-28-18 08:39AM  Aratana Therapeutics (PETX) Soars: Stock Adds 12.4% in Session Zacks
Mar-27-18 07:20AM  Blog Exposure - Vericel Announced Publication of Results from Phase-3 SUMMIT Extension Study ACCESSWIRE
Mar-20-18 08:46AM  Madrigal Pharmaceuticals (MDGL) Soars: Stock Adds 6.5% in Session Zacks
BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase clostridium histolyticum for multiple indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX or Xiapex brand names. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, and plantar fibromatosis, as well as for the treatment of human lipoma and uterine fibroids. The company is also involved in the development of other clinical indications for which collagenase injection has been tested, such as keloids, hypertrophic scars, scarred tendons, glaucoma, herniated intervertebral discs, and as an adjunct to vitrectomy. It has a development and license agreement with Endo Global Ventures. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Lynbrook, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wegman Mark NDirectorSep 11Sale58.661,00058,65565,272Sep 11 09:23 PM
Wegman Mark NDirectorSep 10Sale57.315,500315,20666,272Sep 11 09:23 PM
Gitman PaulDirectorSep 07Sale57.641,00057,63720,000Sep 07 05:31 PM
Schamroth MichaelDirectorAug 29Option Exercise20.0015,000300,00099,000Aug 30 05:36 PM
Gitman PaulDirectorAug 29Sale49.795,000248,97320,000Aug 29 04:20 PM
Gitman PaulDirectorAug 28Sale48.885,000244,41625,000Aug 29 04:20 PM
Gitman PaulDirectorAug 27Sale50.1110,000501,14430,000Aug 29 04:20 PM
Gitman PaulDirectorAug 24Sale51.096,400326,96240,000Aug 27 08:35 PM
Gitman PaulDirectorAug 23Sale51.275,425278,16646,400Aug 27 08:35 PM
Wegman Mark NDirectorAug 23Sale52.564,698246,92971,772Aug 23 08:36 PM
Wegman Mark NDirectorAug 22Sale52.713,802200,39376,470Aug 23 08:36 PM
Wegman TobyDirectorAug 17Sale51.892,500129,728947,473Aug 17 07:48 PM
Estate of Edwin H. Wegman10% OwnerAug 17Sale51.892,500129,728947,473Aug 17 07:50 PM
Wegman ThomasPresidentAug 17Sale51.892,500129,728947,473Aug 17 07:47 PM
Wegman ThomasPresidentAug 16Sale51.2321,0921,080,566291,327Aug 17 07:47 PM
Wegman ThomasPresidentAug 15Sale50.007,921396,056312,419Aug 15 09:02 PM
Wegman ThomasPresidentAug 14Sale51.2115,987818,646320,340Aug 15 09:02 PM